Acute phase of depression treatment - current research and its perspectives on Jessenius Faculty of Medicine
In the previous research at Jessenius Faculty of Medicine in Martin has been studied depression and its treatment from the aspects of the quality of life and functioning of the patients, as well as comparing the efficacy and safety of venlafaxine versus venlafaxine and olanzapine treatment. Last yea...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2016-09-01
|
Series: | European Pharmaceutical Journal |
Subjects: | |
Online Access: | https://doi.org/10.1515/afpuc-2016-0008 |
id |
doaj-ba05962663ee4304b2f7d357feaf7455 |
---|---|
record_format |
Article |
spelling |
doaj-ba05962663ee4304b2f7d357feaf74552021-09-06T19:39:44ZengSciendoEuropean Pharmaceutical Journal2453-67252016-09-01631252810.1515/afpuc-2016-0008afpuc-2016-0008Acute phase of depression treatment - current research and its perspectives on Jessenius Faculty of MedicineOppa M.0Kulhan T.1Nosáľová G.2Ondrejka I.3Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin, Clinic of Psychiatry, Martin SlovakiaComenius University in Bratislava, Jessenius Faculty of Medicine in Martin, Clinic of Psychiatry, Martin, SlovakiaComenius University in Bratislava, Jessenius Faculty of Medicine in Martin, Department of Pharmacology, Martin SlovakiaComenius University in Bratislava, Jessenius Faculty of Medicine in Martin, Clinic of Psychiatry, Martin, SlovakiaIn the previous research at Jessenius Faculty of Medicine in Martin has been studied depression and its treatment from the aspects of the quality of life and functioning of the patients, as well as comparing the efficacy and safety of venlafaxine versus venlafaxine and olanzapine treatment. Last years have been studied the parameters of the autonomic nervous system in the context of depression. Our new work will build on these findings, during the exploration of efficacy and safety of a novel antidepressant vortioxetine in monotherapy and in combination with olanzapine. Since combination of vortixetine and olanzapine is not yet understood, it is unknown whether the effect of the treatment of depressive symptoms and associated problems will be stronger and faster compared to vortioxetine monotherapy.https://doi.org/10.1515/afpuc-2016-0008vortioxetineolanzapinedepression |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Oppa M. Kulhan T. Nosáľová G. Ondrejka I. |
spellingShingle |
Oppa M. Kulhan T. Nosáľová G. Ondrejka I. Acute phase of depression treatment - current research and its perspectives on Jessenius Faculty of Medicine European Pharmaceutical Journal vortioxetine olanzapine depression |
author_facet |
Oppa M. Kulhan T. Nosáľová G. Ondrejka I. |
author_sort |
Oppa M. |
title |
Acute phase of depression treatment - current research and its perspectives on Jessenius Faculty of Medicine |
title_short |
Acute phase of depression treatment - current research and its perspectives on Jessenius Faculty of Medicine |
title_full |
Acute phase of depression treatment - current research and its perspectives on Jessenius Faculty of Medicine |
title_fullStr |
Acute phase of depression treatment - current research and its perspectives on Jessenius Faculty of Medicine |
title_full_unstemmed |
Acute phase of depression treatment - current research and its perspectives on Jessenius Faculty of Medicine |
title_sort |
acute phase of depression treatment - current research and its perspectives on jessenius faculty of medicine |
publisher |
Sciendo |
series |
European Pharmaceutical Journal |
issn |
2453-6725 |
publishDate |
2016-09-01 |
description |
In the previous research at Jessenius Faculty of Medicine in Martin has been studied depression and its treatment from the aspects of the quality of life and functioning of the patients, as well as comparing the efficacy and safety of venlafaxine versus venlafaxine and olanzapine treatment. Last years have been studied the parameters of the autonomic nervous system in the context of depression. Our new work will build on these findings, during the exploration of efficacy and safety of a novel antidepressant vortioxetine in monotherapy and in combination with olanzapine. Since combination of vortixetine and olanzapine is not yet understood, it is unknown whether the effect of the treatment of depressive symptoms and associated problems will be stronger and faster compared to vortioxetine monotherapy. |
topic |
vortioxetine olanzapine depression |
url |
https://doi.org/10.1515/afpuc-2016-0008 |
work_keys_str_mv |
AT oppam acutephaseofdepressiontreatmentcurrentresearchanditsperspectivesonjesseniusfacultyofmedicine AT kulhant acutephaseofdepressiontreatmentcurrentresearchanditsperspectivesonjesseniusfacultyofmedicine AT nosalovag acutephaseofdepressiontreatmentcurrentresearchanditsperspectivesonjesseniusfacultyofmedicine AT ondrejkai acutephaseofdepressiontreatmentcurrentresearchanditsperspectivesonjesseniusfacultyofmedicine |
_version_ |
1717770174859313152 |